Glut‐1 deficiency syndrome: Clinical, genetic, and therapeutic aspects
- 27 December 2004
- journal article
- clinical trial
- Published by Wiley in Annals of Neurology
- Vol. 57 (1), 111-118
- https://doi.org/10.1002/ana.20331
Abstract
Impaired glucose transport across the blood‐brain barrier results in Glut‐1 deficiency syndrome (Glut‐1 DS, OMIM 606777), characterized by infantile seizures, developmental delay, acquired microcephaly, spasticity, ataxia, and hypoglycorrhachia. We studied 16 new Glut‐1 deficiency syndrome patients focusing on clinical and laboratory features, molecular genetics, genotype–phenotype correlation, and treatment. These patients were classified phenotypically into three groups. The mean cerebrospinal fluid glucose concentration was 33.1 ± 4.9mg/dl equal to 37% of the simultaneous blood glucose concentration. The mean cerebrospinal fluid lactate concentration was 1.0 ± 0.3mM, which was less than the normal mean value of 1.63mM. The mean Vmax for the 3‐O‐methyl‐D‐glucose uptake into erythrocytes was 996 fmol/106 red blood cells per second, significantly less (54 ± 11%; t test, p < 0.05) than the mean control value of 1,847. The mean Km value for the patient group (1.4 ± 0.5mM) was similar to the control group (1.7 ± 0.5mM; t test, p > 0.05). We identified 16 rearrangements, including seven missense, one nonsense, one insertion, and seven deletion mutations. Fourteen were novel mutations. There were no obvious correlations between phenotype, genotype, or biochemical measures. The ketogenic diet produced good seizure control. Ann Neurol 2005;57:111–118Keywords
This publication has 34 references indexed in Scilit:
- Facilitated glucose transporter protein type 1 (GLUT1) deficiency syndrome: impaired glucose transport into brain – a reviewEuropean Journal of Pediatrics, 2002
- Autosomal dominant Glut‐1 deficiency syndrome and familial epilepsyAnnals of Neurology, 2001
- Autosomal dominant transmission of GLUT1 deficiencyHuman Molecular Genetics, 2001
- The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel membersMolecular Membrane Biology, 2001
- GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrierNature Genetics, 1998
- Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters.JCI Insight, 1997
- A sink‐specific H+/monosaccharide co‐transporter from Nicotiana tabacum: cloning and heterologous expression in baker’s yeastThe Plant Journal, 1993
- A major superfamily of transmembrane facilitators that catalyse uniport, symport and antiportTrends in Biochemical Sciences, 1993
- Defective Glucose Transport across the Blood-Brain Barrier as a Cause of Persistent Hypoglycorrhachia, Seizures, and Developmental DelayNew England Journal of Medicine, 1991
- Sequence and Structure of a Human Glucose TransporterScience, 1985